December 23rd, 2024: FDA raises concerns about unapproved compounded GLP-1 drugs causing hospitalizations The FDA has expressed concerns about the use of unapproved GLP-1 drugs like semaglutide (Ozempic) and tirzepatide for weight loss
For proper administration and to make sure that this drug is suitable for you, follow all the precautionary measures that are mentioned here: Before taking this medication make sure that you are not allergic or intolerant to Semaglutide or any other ingredient present in this medication
Women, older adults, and those who ate less protein lost more muscle compared to others
Herbal weight loss products: Many contain stimulants or laxatives that can worsen GI side effects or cause dehydration
The point was to make it long acting
Nutritional priorities to support GLP1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
